DK3231803T3 - Dihydroindolizinonderivat - Google Patents

Dihydroindolizinonderivat Download PDF

Info

Publication number
DK3231803T3
DK3231803T3 DK15867764.1T DK15867764T DK3231803T3 DK 3231803 T3 DK3231803 T3 DK 3231803T3 DK 15867764 T DK15867764 T DK 15867764T DK 3231803 T3 DK3231803 T3 DK 3231803T3
Authority
DK
Denmark
Prior art keywords
dihydroindolizinon
derivatives
dihydroindolizinon derivatives
Prior art date
Application number
DK15867764.1T
Other languages
English (en)
Inventor
Motoyuki Tanaka
Takashi Kondo
Yasuo Hirooka
Taihei Nishiyama
Atsushi Hiramatsu
Tomoyuki Koda
Sho Kouyama
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK3231803T3 publication Critical patent/DK3231803T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15867764.1T 2014-12-10 2015-12-09 Dihydroindolizinonderivat DK3231803T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2014249822 2014-12-10
JP2014263251 2014-12-25
JP2015046150 2015-03-09
JP2015160632 2015-08-17
PCT/JP2015/084573 WO2016093285A1 (ja) 2014-12-10 2015-12-09 ジヒドロインドリジノン誘導体

Publications (1)

Publication Number Publication Date
DK3231803T3 true DK3231803T3 (da) 2020-08-24

Family

ID=56107463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15867764.1T DK3231803T3 (da) 2014-12-10 2015-12-09 Dihydroindolizinonderivat

Country Status (22)

Country Link
US (6) US10065955B2 (da)
EP (2) EP3231803B1 (da)
JP (3) JP6610562B2 (da)
KR (1) KR102525392B1 (da)
CN (1) CN107001363B (da)
AU (1) AU2015362422B2 (da)
BR (1) BR112017012146B1 (da)
CA (1) CA2970233C (da)
DK (1) DK3231803T3 (da)
ES (2) ES2814098T3 (da)
HU (1) HUE051080T2 (da)
IL (1) IL252777B (da)
MX (2) MX385021B (da)
MY (1) MY194106A (da)
PH (1) PH12017501067B1 (da)
PL (1) PL3231803T3 (da)
PT (1) PT3231803T (da)
RU (1) RU2707887C2 (da)
SG (1) SG11201704708QA (da)
TW (1) TWI696620B (da)
WO (1) WO2016093285A1 (da)
ZA (1) ZA201704602B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI688564B (zh) 2014-01-31 2020-03-21 美商必治妥美雅史谷比公司 作為凝血因子xia抑制劑之具有雜環p2'基團之巨環化合物
NO2760821T3 (da) 2014-01-31 2018-03-10
WO2016036893A1 (en) 2014-09-04 2016-03-10 Bristol-Myers Squibb Company Diamide macrocycles that are fxia inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
JP6992284B2 (ja) * 2016-06-06 2022-01-13 小野薬品工業株式会社 ジヒドロインドリジノン誘導体を含有する医薬組成物
TWI826599B (zh) * 2018-11-30 2023-12-21 日商小野藥品工業股份有限公司 (3s)-3-[2-(6-胺-2-氟吡啶-3-基)-4-氟-1h-咪唑-5-基]-7-[5-氯-2-(1h-四唑-1-基)苯基]-2,3-二氫吲嗪-5(1h)-酮的新穎結晶
KR102242187B1 (ko) * 2019-06-04 2021-04-20 주식회사 우정바이오 실내 표면 및 공기 살균 정화 장치
EP3998263A4 (en) * 2019-06-28 2023-09-06 Shanghai Jemincare Pharmaceuticals Co., Ltd. Tricyclic compound, preparation method therefor and use thereof
CA3189771A1 (en) * 2020-07-22 2022-01-27 Janssen Pharmaceutica Nv Compounds useful as factor xia inhibitors
JP2024125436A (ja) * 2021-07-20 2024-09-19 小野薬品工業株式会社 イミダゾール化合物の製造方法
TWI833610B (zh) * 2022-03-21 2024-02-21 大陸商上海濟煜醫藥科技有限公司 三并環類化合物製備方法及其中間體
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61385A (en) * 1979-12-06 1984-11-30 Labaz Sanofi Nv 3-(4-(dialkylaminoalkyl)-oxy-benzoyl)-indolizine derivatives,their preparation and pharmaceutical compositions containing them
EP0407342A3 (en) 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
DE4221583A1 (de) 1991-11-12 1993-05-13 Bayer Ag Substituierte biphenylpyridone
DE4407488A1 (de) 1994-03-07 1995-09-14 Bayer Ag Verwendung von Biphenyl- und Pyridylmethylpyridonen
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
ES2334990T3 (es) 2002-02-14 2010-03-18 Pharmacia Corporation Piridinonas sustituidas como moduladores de p38 map quinasa.
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
EP1506967B1 (en) 2003-08-13 2007-11-21 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US7626039B2 (en) 2005-12-14 2009-12-01 Bristol-Myers Squibb Company Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors
MX2009005449A (es) 2006-11-24 2009-06-02 Takeda Pharmaceutical Compuesto heteromonociclico y uso del mismo.
US7803940B2 (en) 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
WO2008076805A2 (en) 2006-12-15 2008-06-26 Bristol-Myers Squibb Company Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
CA2708151A1 (en) 2007-12-11 2009-06-18 Schering Corporation Gamma secretase modulators
AU2011313150A1 (en) 2010-10-07 2013-04-18 Takeda Pharmaceutical Company Limited 1,4-oxazepane derivatives
TW201319068A (zh) * 2011-08-05 2013-05-16 必治妥美雅史谷比公司 作為xia因子抑制劑之環狀p1接合劑
GB2497806A (en) * 2011-12-21 2013-06-26 Ono Pharmaceutical Co Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
CN104136431B (zh) * 2011-12-21 2017-03-15 小野药品工业株式会社 作为凝血因子XIa抑制剂的吡啶酮和嘧啶酮衍生物
CN105829298B (zh) 2014-02-14 2019-02-01 四川海思科制药有限公司 一种吡啶酮或嘧啶酮衍生物、及其制备方法和应用
CN105658641B (zh) * 2014-07-25 2018-04-17 江苏恒瑞医药股份有限公司 氮茚‑酰胺类衍生物、其制备方法及其在医药上的应用

Also Published As

Publication number Publication date
ES2814098T3 (es) 2021-03-26
US10550119B2 (en) 2020-02-04
EP3231803B1 (en) 2020-07-01
US10065955B2 (en) 2018-09-04
US20180334458A1 (en) 2018-11-22
KR20170095845A (ko) 2017-08-23
PT3231803T (pt) 2020-09-03
US10407426B2 (en) 2019-09-10
PH12017501067B1 (en) 2020-11-27
AU2015362422B2 (en) 2019-11-14
WO2016093285A1 (ja) 2016-06-16
TWI696620B (zh) 2020-06-21
CN107001363A (zh) 2017-08-01
IL252777A0 (en) 2017-08-31
EP3231803A4 (en) 2018-08-08
US11566027B2 (en) 2023-01-31
CA2970233A1 (en) 2016-06-16
EP3702357B1 (en) 2022-08-24
PL3231803T3 (pl) 2020-11-02
US10815233B2 (en) 2020-10-27
MY194106A (en) 2022-11-13
ES2927307T3 (es) 2022-11-04
BR112017012146A2 (pt) 2018-01-02
JP2021011506A (ja) 2021-02-04
JPWO2016093285A1 (ja) 2017-09-21
PH12017501067A1 (en) 2017-12-04
IL252777B (en) 2020-11-30
ZA201704602B (en) 2018-08-29
CN107001363B (zh) 2019-06-21
KR102525392B1 (ko) 2023-04-24
MX2021005869A (es) 2021-07-16
US20230138003A1 (en) 2023-05-04
BR112017012146B1 (pt) 2023-11-21
MX385021B (es) 2025-03-14
NZ733574A (en) 2024-03-22
MX2017007551A (es) 2017-10-31
US20170349580A1 (en) 2017-12-07
TW201629059A (zh) 2016-08-16
RU2017124150A3 (da) 2019-07-17
JP2020012004A (ja) 2020-01-23
EP3231803A1 (en) 2017-10-18
JP6791338B2 (ja) 2020-11-25
JP6610562B2 (ja) 2019-11-27
RU2707887C2 (ru) 2019-12-02
HUE051080T2 (hu) 2021-03-01
US20190352304A1 (en) 2019-11-21
CA2970233C (en) 2023-01-03
SG11201704708QA (en) 2017-07-28
US20200140435A1 (en) 2020-05-07
AU2015362422A1 (en) 2017-07-27
RU2017124150A (ru) 2019-01-09
US20210009586A1 (en) 2021-01-14
EP3702357A1 (en) 2020-09-02

Similar Documents

Publication Publication Date Title
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3006072T3 (da) Karadgang
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
LT3204359T (lt) Tetrahidroizochinolino dariniai
DK3222714T3 (da) Phytasemutanter
DK3119396T3 (da) Muscarinreceptoragonister
EP3230438C0 (en) N-GLYCOSYLATION
HUE048321T2 (hu) Karabazol származékok
DK3231803T3 (da) Dihydroindolizinonderivat
EP4011484C0 (en) CARBONIC ANHYDRASE OF THERMOVIBRIO AMMONIFICANS
DK4242916T3 (da) Forstøver
DK3183340T3 (da) Termolabile exonukleaser
DE112015001664A5 (de) Betätigungsaktuator
LT3371168T (lt) Indolin-2-ono dariniai
DK3131898T3 (da) Fluoroalkylfluorenderivativer
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DE112015005041A5 (de) Gargerätevorrichtung
DK3110439T3 (da) Pcsk9-vacciner
DE102014000623A8 (de) Halbhohlnietelement
PL3137460T3 (pl) Pochodne diheterocyklu połączonego cykloalkilem
LT3097076T (lt) Nauji cip-eikozanoidų dariniai
DK3009858T3 (da) Skyradar
DE202014005655U8 (de) llluminationsvorrichtung
IL252908A0 (en) Fumagillol derivatives